Sanger sequencing and NGS panels have been used to identify PLCE1 mutations in nephrotic syndrome patients, while RT-qPCR has also been used for measuring PLCE1 mRNA expression in renal tissues. The gene discussed is PLCE1; the disease is nephrotic syndrome.